| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $709.3M | +37.6% |
| R&D Expense | $300K | +50.0% |
| SG&A Expense | $70.8M | +24.2% |
| Operating Income | $118.4M | +42.7% |
| Pre-tax Income | $115.2M | +40.3% |
| Income Tax | $30.4M | +44.0% |
| Net Income | $84.8M | +39.1% |
| EPS (Basic) | $3.60 | +38.5% |
| EPS (Diluted) | $3.58 | +38.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.1M | -60.8% |
| Accounts Receivable | $114.4M | +83.0% |
| Inventory | $40.7M | +37.9% |
| Current Assets | $191.3M | +22.5% |
| Total Assets | $794.2M | +50.7% |
| Current Liabilities | $115.8M | +35.6% |
| Long-term Debt | $89.4M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $92.6M | +1.7% |
| Capital Expenditures | $47.7M | +98.0% |
| Investing Cash Flow | -$207.3M | -205.4% |
| Financing Cash Flow | $80.4M | +333.2% |
| Free Cash Flow | $44.9M | -32.9% |
| Total Liabilities |
| $364.0M |
| +97.0% |
| Stockholders' Equity | $430.2M | +25.8% |